Healthcare

Divi's Laboratories Limited

DIVISLAB · NIFTYNEXT50 · NIFTYPHARMA

9,144.50

+1.27%

close, 16 Oct 2026

Traded value

₹712 Cr

#19 in the basket

Volume

7.78 L

Session range

8,985.50–9,248.00

Low to high

Open

9,030.50

First trade

Closing price, last 24 sessions collected9,023.00 – 9,624.00

Where this sits in the session

Measured against the 153 priced constituents the platform tracks, and against the 22 of them in Healthcare.

Share of basket turnover

1.2%

₹712 Cr of the session, ranked #19 of 153

Share of sector turnover

19%

#1 of 22 in Healthcare

Against the sector

+1.78%

This name +1.27% against a −0.51% sector average

Sector breadth

7 / 15

Advanced against declined, of 22 traded

Most traded in Healthcare this session

Other constituents in the same sector, ranked by traded value for this session, with their close, change and traded value.
Company	Close	Change	Traded value
Apollo Hospitals Enterprise LimitedAPOLLOHOSP	7,890.00	+0.01%	₹432 Cr
Max Healthcare Institute LimitedMAXHEALTH	846.00	−1.40%	₹341 Cr
Laurus Labs LimitedLAURUSLABS	2,060.10	+2.06%	₹331 Cr
Sun Pharmaceutical Industries LimitedSUNPHARMA	1,758.80	−0.29%	₹268 Cr
Mankind Pharma LimitedMANKIND	2,275.50	−3.07%	₹202 Cr
Zydus Lifesciences LimitedZYDUSLIFE	1,123.00	−1.51%	₹180 Cr
Dr. Reddy's Laboratories LimitedDRREDDY	1,233.00	+1.17%	₹155 Cr
Glenmark Pharmaceuticals LimitedGLENMARK	2,226.70	−1.06%	₹155 Cr

Traded value is closing price multiplied by reported volume. Shares are measured against the 153 deduplicated constituents of the nine tracked indices, not against the whole exchange. The sector average is unweighted, so a small member moves it as much as a large one; the member count sits beside it. Every sector ↗

Disclosed transactions

No bulk or block transactions disclosed in this security across the sessions collected.

Substantial acquisitions

No SEBI SAST filing has been recorded against this company since collection began.

Prices sourced from Yahoo Finance ↗. Transactions and SAST filings sourced from the National Stock Exchange ↗. No content on this page constitutes a recommendation, and no entry is inferred. Every line records a disclosure made by a publishing authority.